ConvaTec Group Plc

Block Listing Application

Reading, United Kingdom - 20 December 2021

An application has been made to the Financial Conduct Authority and the London Stock Exchange for a block listing totalling 20,000,000 ordinary shares of 10 pence each ("Shares") to be admitted to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities. When issued these Shares will rank pari passu with the existing ordinary shares.

These Shares are being reserved under a block listing and will be issued from time to time pursuant to the following scheme(s):

Admission of the Shares is expected on 21 December 2021.

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec                      +44 (0)782 644 7807

ir@convatec.com

Media

Buchanan: Chris Lane                                                              +44 (0)207 466 5000                                                                                                 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com